Molecular Templates, Inc. Announces $45 Million Debt Financing From K2 HealthVentures
22 mai 2020 08h00 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, May 22, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” “MTEM” or the “Company”), a clinical-stage biopharmaceutical company focused on the...
New Data on Molecular Templates’ Engineered Toxin Bodies to be Presented at the American Association of Cancer Research (AACR) Virtual Annual Meeting II
15 mai 2020 07h00 HE
|
Molecular Templates, Inc.
AUSTIN, Texas,, May 15, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and...
Molecular Templates to Participate in Two May Virtual Investor Conferences
13 mai 2020 16h30 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, May 13, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and...
Molecular Templates, Inc. Reports First Quarter 2020 Financial Results
11 mai 2020 16h30 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, May 11, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and...
Molecular Templates, Inc. Announces that the 2020 Annual Meeting of Stockholders Will be Held in Virtual Format
07 mai 2020 16h30 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, May 07, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (the “Company”) (Nasdaq: MTEM) announced today that the 2020 Annual Meeting of Stockholders (the “Annual Meeting”) will be...
Molecular Templates, Inc. Reports Fourth Quarter 2019 Financial Results
12 mars 2020 16h30 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, March 12, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and...
Molecular Templates to Present at Three March Investor Conferences
28 févr. 2020 08h00 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and...
Molecular Templates, Inc. Announces Dosing of First Subject in Phase I Study of TAK-169 in Relapsed/Refractory Multiple Myeloma
19 févr. 2020 07h00 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and...
Molecular Templates Provides Corporate Update and Outlines 2020 Milestones
08 janv. 2020 08h00 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM) a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s...
Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors
19 déc. 2019 07h00 HE
|
Molecular Templates, Inc.
AUSTIN, Texas, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM) a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s...